Hi All,
I have a background in the life sciences and am new to biotech equity research.
Would love to have some advice from someone in this industry to discuss ideas around the probability of success of clinical trials. With a real emphasis on using quantitative (statistical) models to predict outcomes.
What are you guys using? How do you approach this type of analysis?
What frameworks exist for this?
Thank you!
| +81 | Q&A - Buyside Equity Research Analyst/PM | 29 | 4d | |
| +32 | How the heck do you learn all of this stuff? | 5 | 1w | |
| +28 | My experience on the sell side | 20 | 2w | |
| +28 | Getting Frustrated | 10 | 4w | |
| +24 | Clues in Financial Reporting Analysis | 7 | 17h | |
| +18 | Biotech ER vs IB | 16 | 4w | |
| +17 | Am i fairly compensated? | 9 | 1d | |
| +14 | Heard they don’t model at Oppenheimer | 10 | 2w | |
| +14 | Data Science to PM | 8 | 1w | |
| +12 | ER - Remote Jobs? | 8 | 4d |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Nisi nihil exercitationem est voluptas rerum cumque at tenetur. Minus molestiae est numquam fuga corrupti. Unde illum et veritatis molestias veniam. Enim voluptas harum sed minus doloremque.
Cupiditate corporis corporis aperiam consectetur modi illum quasi. Neque necessitatibus iste hic reprehenderit est porro laboriosam. Dolorem dolorem sed cupiditate voluptatem.
Dolorem et inventore sed deleniti. Qui ut sit dolore rem et exercitationem. Sit quidem iste dolore quia ullam minima et.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...